Headline News

The combined use of selective serotonin reuptake inhibitors and methylphenidate did not significantly increase adverse event risk among adults with ADHD and comorbid depression, according to a study published in JAMA Network Open.

A multidisciplinary group of scientists recently launched the Society for Equity Neuroscience to address racial and ethnic disparities in nervous system health through research.

ICP-488 demonstrated “excellent” efficacy and safety for the treatment of moderate to severe plaque psoriasis in adults, InnoCare Pharma announced in a press release.

In this video from the Academic Orthopaedic Consortium Business & Leadership Symposium, Scott D. Boden, MD, discusses ways to achieve an effective and sustainable, market competitive compensation plan.

In this video, Barbara Blodi, MD, discusses advancements in complement inhibition treatments for geographic atrophy.

The Society for Cardiovascular Angiography and Interventions has released a consensus statement on how catheterization laboratories should manage the technical aspects of PCI for patients with STEMI.

Vaccination coverage among kindergarteners in the United States is still declining from pre-pandemic levels, and some states are reporting exemption rates of more than 5%, according to the latest CDC data.

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data.

Children and adolescents diagnosed with COVID-19 were more likely to develop new-onset type 2 diabetes than those who had other respiratory infections, according to data published in JAMA Network Open.